Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.36 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5607138 | 0.76 | HTR6 (0.47) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL22263422 | 0.74 | CA4 (0.41) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL2090405 | 0.74 | CA4 (0.41) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL4446975 | 0.70 | HTR6 (0.44) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL3299477 | 0.70 | PTGS2 (0.36) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL94530 | 0.70 | HTR6 (0.50) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL21647647 | 0.70 | TSHR (0.46) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL2937203 | 0.69 | HTR6 (0.47) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL3253436 | 0.69 | HTR6 (0.47) | CA4HTR6PSIP1ALDH1A1CA12 | |
| SCHEMBL20419428 | 0.69 | HTR6 (0.47) | CA4HTR6PSIP1ALDH1A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100565338-C | What comprise the Photoactive compounds potpourri is used for the lithographic photoetching compositions of deep ultraviolet | AZ ELECTRONIC MATERIALS JAPAN (JP) | 2009-12-02 | — | — | CN | disclosed |
| US-6991888-B2 | Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2006-01-31 | — | — | US | disclosed |
| CN-1659477-A | Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds | AZ ELECTRONIC MATERIALS USA (JP) | 2005-08-24 | — | — | CN | disclosed |
| EP-1516229-A2 | PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS | AZ Electronic Materials USA Corp. (US) | 2005-03-23 | — | — | EP | disclosed |
| US-20030235782-A1 | Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds | MERCK PATENT GMBH (DE) | 2003-12-25 | — | — | US | disclosed |
| US-20030235775-A1 | Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds | CLARIANT INTERNATIONAL LTD (CH) | 2003-12-25 | — | — | US | disclosed |
| WO-2003107093-A2 | PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS | CLARIANT INTERNATIONAL LTD (CH) | 2003-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030235782-A1 | Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds | SUN2, UROD, ERCC1 | CA4 125/4885HTR6 4314/4885PSIP1 2361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.